<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33051352</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>47</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>18</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Neutral Lipid Cacostasis Contributes to Disease Pathogenesis in Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>9137</StartPage><EndPage>9147</EndPage><MedlinePgn>9137-9147</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1523/JNEUROSCI.1388-20.2020</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neuromuscular disease characterized by motor neuron (MN) death. Lipid dysregulation manifests during disease; however, it is unclear whether lipid homeostasis is adversely affected in the in the spinal cord gray matter (GM), and if so, whether it is because of an aberrant increase in lipid synthesis. Moreover, it is unknown whether lipid dysregulation contributes to MN death. Here, we show that cholesterol ester (CE) and triacylglycerol levels are elevated several-fold in the spinal cord GM of male sporadic ALS patients. Interestingly, HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, was reduced in the spinal cord GM of ALS patients. Increased cytosolic phospholipase A2 activity and lyso-phosphatidylcholine (Lyso-PC) levels in ALS patients suggest that CE accumulation was driven by acyl group transfer from PC to cholesterol. Notably, Lyso-PC, a byproduct of CE synthesis, was toxic to human MNs <i>in vitro</i> Elevations in CE, triacylglycerol, and Lyso-PC were also found in the spinal cord of SOD1<sup>G93A</sup> mice, a model of ALS. Similar to ALS patients, a compensatory downregulation of cholesterol synthesis occurred in the spinal cord of SOD1<sup>G93A</sup> mice; levels of sterol regulatory element binding protein 2, a transcriptional regulator of cholesterol synthesis, progressively declined. Remarkably, overexpressing sterol regulatory element binding protein 2 in the spinal cord of normal mice to model CE accumulation led to ALS-like lipid pathology, MN death, astrogliosis, paralysis, and reduced survival. Thus, spinal cord lipid dysregulation in ALS likely contributes to neurodegeneration and developing therapies to restore lipid homeostasis may lead to a treatment for ALS.<b>SIGNIFICANCE STATEMENT</b> Neurons that control muscular function progressively degenerate in patients with amyotrophic lateral sclerosis (ALS). Lipid dysregulation is a feature of ALS; however, it is unclear whether disrupted lipid homeostasis (i.e., lipid cacostasis) occurs proximal to degenerating neurons in the spinal cord, what causes it, and whether it contributes to neurodegeneration. Here we show that lipid cacostasis occurs in the spinal cord gray matter of ALS patients. Lipid accumulation was not associated with an aberrant increase in synthesis or reduced hydrolysis, as enzymatic and transcriptional regulators of lipid synthesis were downregulated during disease. Last, we demonstrated that genetic induction of lipid cacostasis in the CNS of normal mice was associated with ALS-like lipid pathology, astrogliosis, neurodegeneration, and clinical features of ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 the authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dodge</LastName><ForeName>James C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Rare and Neurological Diseases Therapeutic Area james.dodge@sanofi.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Elizabeth H</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Rare and Neurological Diseases Therapeutic Area.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jinlong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Rare and Neurological Diseases Therapeutic Area.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sardi</LastName><ForeName>S Pablo</ForeName><Initials>SP</Initials><Identifier Source="ORCID">0000-0001-9805-3677</Identifier><AffiliationInfo><Affiliation>Rare and Neurological Diseases Therapeutic Area.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bialas</LastName><ForeName>Allison R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Rare and Neurological Diseases Therapeutic Area.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taksir</LastName><ForeName>Tatyana V</ForeName><Initials>TV</Initials><AffiliationInfo><Affiliation>Global Discovery Pathology, Sanofi R+D, Framingham, Massachusetts 01701.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bangari</LastName><ForeName>Dinesh S</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0002-9909-1146</Identifier><AffiliationInfo><Affiliation>Global Discovery Pathology, Sanofi R+D, Framingham, Massachusetts 01701.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shihabuddin</LastName><ForeName>Lamya S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Rare and Neurological Diseases Therapeutic Area.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HHSN275200900011C</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002788">Cholesterol Esters</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008244">Lysophosphatidylcholines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D043562">Receptors, G-Protein-Coupled</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054507">Receptors, Phospholipase A2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C528686">SREB2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014280">Triglycerides</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002788" MajorTopicYN="N">Cholesterol Esters</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="N">Gray Matter</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050356" MajorTopicYN="Y">Lipid Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008244" MajorTopicYN="N">Lysophosphatidylcholines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043562" MajorTopicYN="N">Receptors, G-Protein-Coupled</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054507" MajorTopicYN="N">Receptors, Phospholipase A2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014280" MajorTopicYN="N">Triglycerides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>14</Day><Hour>9</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33051352</ArticleId><ArticleId IdType="pmc">PMC7673008</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.1388-20.2020</ArticleId><ArticleId IdType="pii">JNEUROSCI.1388-20.2020</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdel-Khalik J, Yutuc E, Crick PJ, Gustafsson JA, Warner M, Roman G, Talbot K, Gray E, Griffiths WJ, Turner MR, Wang Y (2017) Defective cholesterol metabolism in amyotrophic lateral sclerosis. J Lipid Res 58:267&#x2013;278. 10.1194/jlr.P071639</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.P071639</ArticleId><ArticleId IdType="pmc">PMC5234729</ArticleId><ArticleId IdType="pubmed">27811233</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiba S, Yoneda Y, Ohno S, Nemoto M, Sato T (2003) Oxidized LDL activates phospholipase A2 to supply fatty acids required for cholesterol esterification. J Lipid Res 44:1676&#x2013;1685. 10.1194/jlr.M300012-JLR200</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M300012-JLR200</ArticleId><ArticleId IdType="pubmed">12777475</ArticleId></ArticleIdList></Reference><Reference><Citation>Amarilio R, Ramachandran S, Sabanay H, Lev S (2005) Differential regulation of endoplasmic reticulum structure through VAP-Nir protein interaction. J Biol Chem 280:5934&#x2013;5944. 10.1074/jbc.M409566200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M409566200</ArticleId><ArticleId IdType="pubmed">15545272</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson S, Gustafsson N, Warner M, Gustafsson JA (2005) Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice. Proc Natl Acad Sci USA 102:3857&#x2013;3862. 10.1073/pnas.0500634102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0500634102</ArticleId><ArticleId IdType="pmc">PMC553330</ArticleId><ArticleId IdType="pubmed">15738425</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews JM. (1975) The fine structure of the cervical spinal cord, ventral root and brachial nerves in the wobbler (wr) mouse. J Neuropathol Exp Neurol 34:12&#x2013;27. 10.1097/00005072-197501000-00002</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-197501000-00002</ArticleId><ArticleId IdType="pubmed">1117319</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker DJ, Blackburn DJ, Keatinge M, Sokhi D, Viskaitis P, Heath PR, Ferraiuolo L, Kirby J, Shaw PJ (2015) Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 (G93A) mouse model of amyotrophic lateral sclerosis. Front Cell Neurosci 9:410. 10.3389/fncel.2015.00410</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00410</ArticleId><ArticleId IdType="pmc">PMC4606544</ArticleId><ArticleId IdType="pubmed">26528138</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu ZS, Wong PC, Brown RH Jr, Price DL, Sisodia SS, Cleveland DW (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 91:8292&#x2013;8296. 10.1073/pnas.91.17.8292</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.17.8292</ArticleId><ArticleId IdType="pmc">PMC44592</ArticleId><ArticleId IdType="pubmed">8058797</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt DR, Guarnieri M, Wong PC, Lee MK, Slunt HS, Xu ZS, Sisodia SS, Price DL, Cleveland DW (1995) Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect WT subunit function. J Biol Chem 270:3234&#x2013;3238. 10.1074/jbc.270.7.3234</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.7.3234</ArticleId><ArticleId IdType="pubmed">7852409</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MS, Goldstein JL (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89:331&#x2013;340. 10.1016/s0092-8674(00)80213-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)80213-5</ArticleId><ArticleId IdType="pubmed">9150132</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaves-Filho AB, Pinto IF, Dantas LS, Xavier AM, Inague A, Faria RL, Medeiros MH, Glezer I, Yoshinaga MY, Miyamoto S (2019) Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis. Sci Rep 9:11642. 10.1038/s41598-019-48059-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48059-7</ArticleId><ArticleId IdType="pmc">PMC6691112</ArticleId><ArticleId IdType="pubmed">31406145</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Yazdani S, Piehl F, Magnusson PK, Fang F (2018) Polygenic link between blood lipids and amyotrophic lateral sclerosis. Neurobiol Aging 67:202.e1&#x2013;202.e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">29685649</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang PM, Ling J, Jeong YH, Price DL, Aja SM, Wong PC (2010) Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc Natl Acad Sci USA 107:16320&#x2013;16324. 10.1073/pnas.1002176107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1002176107</ArticleId><ArticleId IdType="pmc">PMC2941284</ArticleId><ArticleId IdType="pubmed">20660762</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler RG, Pedersen WA, Camandola S, Rothstein JD, Mattson MP (2002) Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann Neurol 52:448&#x2013;457. 10.1002/ana.10312</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10312</ArticleId><ArticleId IdType="pubmed">12325074</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B, Santillo M, Seru R, Damiano S, Matrone G, Wilson RR, Mondola P (2004) Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase gene expression by CuZn superoxide dismutase in human fibroblasts and HepG2 cells. Gene Expr 12:29&#x2013;38. 10.3727/000000004783992198</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/000000004783992198</ArticleId><ArticleId IdType="pmc">PMC6009104</ArticleId><ArticleId IdType="pubmed">15473258</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC. (2017) Lipid involvement in neurodegenerative diseases of the motor system: insights from lysosomal storage diseases. Front Mol Neurosci 10:356. 10.3389/fnmol.2017.00356</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00356</ArticleId><ArticleId IdType="pmc">PMC5675881</ArticleId><ArticleId IdType="pubmed">29163032</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC, Treleaven CM, Pacheco J, Cooper S, Bao C, Abraham M, Cromwell M, Sardi SP, Chuang WL, Sidman RL, Cheng SH, Shihabuddin LS (2015) Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 112:8100&#x2013;8105. 10.1073/pnas.1508767112</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1508767112</ArticleId><ArticleId IdType="pmc">PMC4491749</ArticleId><ArticleId IdType="pubmed">26056266</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Kuhnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC (2011) Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol 258:613&#x2013;617. 10.1007/s00415-010-5805-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5805-z</ArticleId><ArticleId IdType="pubmed">21128082</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, Bittar R, Seilhean D, Hauw JJ, Lacomblez L, Loeffler JP, Meininger V (2008) Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70:1004&#x2013;1009. 10.1212/01.wnl.0000285080.70324.27</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Feinberg AP. (2007) Phenotypic plasticity and the epigenetics of human disease. Nature 447:433&#x2013;440. 10.1038/nature05919</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05919</ArticleId><ArticleId IdType="pubmed">17522677</ArticleId></ArticleIdList></Reference><Reference><Citation>Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34:521&#x2013;533. 10.1016/s0896-6273(02)00682-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(02)00682-7</ArticleId><ArticleId IdType="pubmed">12062037</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanrieder J, Ewing AG (2014) Spatial elucidation of spinal cord lipid and metabolite regulations in amyotrophic lateral sclerosis. Sci Rep 4:5266. 10.1038/srep05266</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep05266</ArticleId><ArticleId IdType="pmc">PMC4053717</ArticleId><ArticleId IdType="pubmed">24919836</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A, Croixmarie V, Priestman DA, Rosenbohm A, Dirrig-Grosch S, D'Ambra E, Huebecker M, Hussain G, Boursier-Neyret C, Echaniz-Laguna A, Ludolph AC, Platt FM, Walther B, Spedding M, Loeffler JP, Gonzalez De Aguilar JL (2015) Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase. Hum Mol Genet 24:7390&#x2013;7405. 10.1093/hmg/ddv439</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv439</ArticleId><ArticleId IdType="pmc">PMC4664174</ArticleId><ArticleId IdType="pubmed">26483191</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton JD, Shimomura I, Brown MS, Hammer RE, Goldstein JL, Shimano H (1998) Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J Clin Invest 101:2331&#x2013;2339. 10.1172/JCI2961</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI2961</ArticleId><ArticleId IdType="pmc">PMC508822</ArticleId><ArticleId IdType="pubmed">9616204</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiaei M, Kipiani K, Petri S, Choi DK, Chen J, Calingasan NY, Beal MF (2005) Integrative role of cPLA with COX-2 and the effect of non-steroidal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem 93:403&#x2013;411. 10.1111/j.1471-4159.2005.03024.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03024.x</ArticleId><ArticleId IdType="pubmed">15816863</ArticleId></ArticleIdList></Reference><Reference><Citation>Klopfleisch S, Merkler D, Schmitz M, Kloppner S, Schedensack M, Jeserich G, Althaus HH, Bruck W (2008) Negative impact of statins on oligodendrocytes and myelin formation in vitro and in vivo. J Neurosci 28:13609&#x2013;13614. 10.1523/JNEUROSCI.2765-08.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2765-08.2008</ArticleId><ArticleId IdType="pmc">PMC6671750</ArticleId><ArticleId IdType="pubmed">19074034</ArticleId></ArticleIdList></Reference><Reference><Citation>Lastres-Becker I, Brodesser S, Lutjohann D, Azizov M, Buchmann J, Hintermann E, Sandhoff K, Schurmann A, Nowock J, Auburger G (2008) Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice. Hum Mol Genet 17:1465&#x2013;1481. 10.1093/hmg/ddn035</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn035</ArticleId><ArticleId IdType="pubmed">18250099</ArticleId></ArticleIdList></Reference><Reference><Citation>Leventhal AR, Chen W, Tall AR, Tabas I (2001) Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux. J Biol Chem 276:44976&#x2013;44983. 10.1074/jbc.M106455200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M106455200</ArticleId><ArticleId IdType="pubmed">11579092</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Ruan X, Yang L, Kiesewetter K, Zhao Y, Luo H, Chen Y, Gucek M, Zhu J, Cao H (2015) A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice. Cell Metab 21:455&#x2013;467. 10.1016/j.cmet.2015.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.02.004</ArticleId><ArticleId IdType="pmc">PMC4350020</ArticleId><ArticleId IdType="pubmed">25738460</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Wang J (2019) C9orf72-dependent lysosomal functions regulate epigenetic control of autophagy and lipid metabolism. Autophagy 15:913&#x2013;914. 10.1080/15548627.2019.1580106</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1580106</ArticleId><ArticleId IdType="pmc">PMC6526819</ArticleId><ArticleId IdType="pubmed">30767689</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, Hammar N, Malmstrom H, Ingre C, Jungner I, Ye W, Fang F, Walldius G (2017) Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: a more than 20-year follow-up of the Swedish AMORIS cohort. Ann Neurol 81:718&#x2013;728. 10.1002/ana.24936</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24936</ArticleId><ArticleId IdType="pubmed">28437840</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondola P, Bifulco M, Seru R, Annella T, Ciriolo MR, Santillo M (2000) Presence of CuZn superoxide dismutase in human serum lipoproteins. FEBS Lett 467:57&#x2013;60. 10.1016/s0014-5793(00)01123-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0014-5793(00)01123-6</ArticleId><ArticleId IdType="pubmed">10664456</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondola P, Seru R, Santillo M, Damiano S, Bifulco M, Laezza C, Formisano P, Rotilio G, Ciriolo MR (2002) Effect of Cu,Zn superoxide dismutase on cholesterol metabolism in human hepatocarcinoma (HepG2) cells. Biochem Biophys Res Commun 295:603&#x2013;609. 10.1016/s0006-291x(02)00720-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0006-291x(02)00720-9</ArticleId><ArticleId IdType="pubmed">12099681</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore F, Riordan JF (1990) Angiogenin activates phospholipase C and elicits a rapid incorporation of fatty acid into cholesterol esters in vascular smooth muscle cells. Biochemistry 29:228&#x2013;233. 10.1021/bi00453a031</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00453a031</ArticleId><ArticleId IdType="pubmed">2322543</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris LL, Hartman IZ, Jun DJ, Seemann J, DeBose-Boyd RA (2014) Sequential actions of the AAA-ATPase valosin-containing protein (VCP)/p97 and the proteasome 19 S regulatory particle in sterol-accelerated, endoplasmic reticulum (ER)-associated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem 289:19053&#x2013;19066. 10.1074/jbc.M114.576652</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.576652</ArticleId><ArticleId IdType="pmc">PMC4081943</ArticleId><ArticleId IdType="pubmed">24860107</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouzat K, Molinari N, Kantar J, Polge A, Corcia P, Couratier P, Clavelou P, Juntas-Morales R, Pageot N, Lobaccaro JA, Raoul C, Lumbroso S, Camu W (2018) Liver X receptor gene variants modulate ALS phenotype. Mol Neurobiol 55:1959&#x2013;1965. 10.1007/s12035-017-0453-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0453-2</ArticleId><ArticleId IdType="pubmed">28244008</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutemberezi V, Guillemot-Legris O, Muccioli GG (2016) Oxysterols: from cholesterol metabolites to key mediators. Prog Lipid Res 64:152&#x2013;169. 10.1016/j.plipres.2016.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plipres.2016.09.002</ArticleId><ArticleId IdType="pubmed">27687912</ArticleId></ArticleIdList></Reference><Reference><Citation>Nefussy B, Hirsch J, Cudkowicz ME, Drory VE (2011) Gender-based effect of statins on functional decline in amyotrophic lateral sclerosis. J Neurol Sci 300:23&#x2013;27. 10.1016/j.jns.2010.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2010.10.011</ArticleId><ArticleId IdType="pubmed">21056430</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieweg K, Schaller H, Pfrieger FW (2009) Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. J Neurochem 109:125&#x2013;134. 10.1111/j.1471-4159.2009.05917.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.05917.x</ArticleId><ArticleId IdType="pubmed">19166509</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Toole D, Ingram J, Welch V, Bardsley K, Haven T, Nunamaker C, Wells G (1994) An inherited lower motor neuron disease of pigs: clinical signs in two litters and pathology of an affected pig. J Vet Diagn Invest 6:62&#x2013;71. 10.1177/104063879400600112</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/104063879400600112</ArticleId><ArticleId IdType="pubmed">8011784</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Toole D, McAllister MM, Griggs K (1995) Iatrogenic compressive lumbar myelopathy and radiculopathy in adult cattle following injection of an adjuvanted bacterin into loin muscle: histopathology and ultrastructure. J Vet Diagn Invest 7:237&#x2013;244. 10.1177/104063879500700212</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/104063879500700212</ArticleId><ArticleId IdType="pubmed">7619907</ArticleId></ArticleIdList></Reference><Reference><Citation>Ousman SS, David S (2000) Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 30:92&#x2013;104. 10.1002/(SICI)1098-1136(200003)30:1&lt;92::AID-GLIA10&gt;3.0.CO;2-W</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1136(200003)30:1&lt;92::AID-GLIA10&gt;3.0.CO;2-W</ArticleId><ArticleId IdType="pubmed">10696148</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinson GM, Dayas CV, Smith DW (2016) Perturbed cholesterol homeostasis in aging spinal cord. Neurobiol Aging 45:123&#x2013;135. 10.1016/j.neurobiolaging.2016.05.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.05.017</ArticleId><ArticleId IdType="pubmed">27459933</ArticleId></ArticleIdList></Reference><Reference><Citation>Passini MA, Watson DJ, Vite CH, Landsburg DJ, Feigenbaum AL, Wolfe JH (2003) Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice. J Virol 77:7034&#x2013;7040. 10.1128/jvi.77.12.7034-7040.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.77.12.7034-7040.2003</ArticleId><ArticleId IdType="pmc">PMC156185</ArticleId><ArticleId IdType="pubmed">12768022</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, Ghasemi M, Brown RH Jr (2015) Emerging mechanisms of molecular pathology in ALS. J Clin Invest 125:2548. 10.1172/JCI82693</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI82693</ArticleId><ArticleId IdType="pmc">PMC4518693</ArticleId><ArticleId IdType="pubmed">26030230</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan G, Xie C, Dietschy JM, Turley SD (2003) Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Brain Res Dev Brain Res 146:87&#x2013;98. 10.1016/j.devbrainres.2003.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devbrainres.2003.09.015</ArticleId><ArticleId IdType="pubmed">14643015</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinowitz JE, Rolling F, Li C, Conrath H, Xiao W, Xiao X, Samulski RJ (2002) Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 76:791&#x2013;801. 10.1128/jvi.76.2.791-801.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.76.2.791-801.2002</ArticleId><ArticleId IdType="pmc">PMC136844</ArticleId><ArticleId IdType="pubmed">11752169</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolo AP, Palmeira CM, Holy JM, Wallace KB (2004) Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis. Toxicol Sci 79:196&#x2013;204. 10.1093/toxsci/kfh078</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfh078</ArticleId><ArticleId IdType="pubmed">14976352</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanhueza M, Chai A, Smith C, McCray BA, Simpson TI, Taylor JP, Pennetta G (2015) Network analyses reveal novel aspects of ALS pathogenesis. PLoS Genet 11:e1005107. 10.1371/journal.pgen.1005107</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1005107</ArticleId><ArticleId IdType="pmc">PMC4380362</ArticleId><ArticleId IdType="pubmed">25826266</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata N, Kakita A, Takahashi H, Ihara Y, Nobukuni K, Fujimura H, Sakoda S, Kobayashi M (2010) Increased expression and activation of cytosolic phospholipase A2 in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. Acta Neuropathol 119:345&#x2013;354. 10.1007/s00401-009-0636-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0636-7</ArticleId><ArticleId IdType="pubmed">20066429</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomonov Y, Hadad N, Levy R (2016) Reduction of cytosolic phospholipase A2alpha upregulation delays the onset of symptoms in SOD1G93A mouse model of amyotrophic lateral sclerosis. J Neuroinflammation 13:134. 10.1186/s12974-016-0602-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0602-y</ArticleId><ArticleId IdType="pmc">PMC4888471</ArticleId><ArticleId IdType="pubmed">27250836</ArticleId></ArticleIdList></Reference><Reference><Citation>Steck TL, Lange Y (2010) Cell cholesterol homeostasis: mediation by active cholesterol. Trends Cell Biol 20:680&#x2013;687. 10.1016/j.tcb.2010.08.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2010.08.007</ArticleId><ArticleId IdType="pmc">PMC2967630</ArticleId><ArticleId IdType="pubmed">20843692</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein O, Ben-Naim M, Dabach Y, Hollander G, Stein Y (1992) Modulation of sphingomyelinase-induced cholesterol esterification in fibroblasts, CaCo2 cells, macrophages and smooth muscle cells. Biochim Biophys Acta 1126:291&#x2013;297. 10.1016/0005-2760(92)90243-o</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0005-2760(92)90243-o</ArticleId><ArticleId IdType="pubmed">1637857</ArticleId></ArticleIdList></Reference><Reference><Citation>Su TP, Hayashi T, Maurice T, Buch S, Ruoho AE (2010) The sigma-1 receptor chaperone as an inter-organelle signaling modulator. Trends Pharmacol Sci 31:557&#x2013;566. 10.1016/j.tips.2010.08.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2010.08.007</ArticleId><ArticleId IdType="pmc">PMC2993063</ArticleId><ArticleId IdType="pubmed">20869780</ArticleId></ArticleIdList></Reference><Reference><Citation>Su XW, Nandar W, Neely EB, Simmons Z, Connor JR (2016) Statins accelerate disease progression and shorten survival in SOD1(G93A) mice. Muscle Nerve 54:284&#x2013;291. 10.1002/mus.25048</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25048</ArticleId><ArticleId IdType="pmc">PMC5848093</ArticleId><ArticleId IdType="pubmed">26799243</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokutake Y, Gushima K, Miyazaki H, Shimosato T, Yonekura S (2015) ALS-associated P56S-VAPB mutation restrains 3T3-L1 preadipocyte differentiation. Biochem Biophys Res Commun 460:831&#x2013;837. 10.1016/j.bbrc.2015.03.118</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2015.03.118</ArticleId><ArticleId IdType="pubmed">25824044</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu CY, Theusch E, Lo K, Mangravite LM, Naidoo D, Kutilova M, Medina MW (2014) HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism. Hum Mol Genet 23:319&#x2013;332. 10.1093/hmg/ddt422</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt422</ArticleId><ArticleId IdType="pmc">PMC3869353</ArticleId><ArticleId IdType="pubmed">24001602</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>